Committed to technological innovation as the core driving force, we focus on independent R&D of novel electrochemical sensing technologies. Our core product addresses precision glucose management for diabetes. Featuring a calibration-free, high-accuracy, low-cost CGM continuous glucose monitoring system that can be worn for up to 14 days, we have successfully obtained the Class III medical device registration certificate in China.

Leveraging our self-developed flexible microneedle sensors, supported by core processes such as precision electrode screen printing and composite functional layer spray coating, combined with our proprietary automated production and testing system, we have significantly improved sensor yield and batch-to-batch consistency while effectively controlling mass production costs. The product boasts an elegant and compact design, is light and comfortable to wear, and offers both medical-grade detection accuracy and high cost-effectiveness. It is widely suitable for scenarios such as home-based chronic disease management and clinical glucose monitoring, demonstrating strong industrialization capabilities and advantages for large-scale commercial adoption.